National Guideline Clearinghouse | Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma.

full-text:
National Guideline Clearinghouse | Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma.

March 25, 2013

Guideline Title

Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma.

 

Bibliographic Source(s)

National Institute for Health and Clinical Excellence (NICE). Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma. London (UK): National Institute for Health and Clinical Excellence (NICE); 2012 Dec. 45 p. (Technology appraisal guidance; no. 268).

 

Guideline Status

This is the current release of the guideline.